• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青蒿素抗疟作用靶点研究进展。

Advances in the research on the targets of anti-malaria actions of artemisinin.

机构信息

Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, Ministry of Education, Gannan Medical University, Ganzhou, China; Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.

Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, Ministry of Education, Gannan Medical University, Ganzhou, China; Department of Anaesthesiology, Singapore General Hospital, Singapore.

出版信息

Pharmacol Ther. 2020 Dec;216:107697. doi: 10.1016/j.pharmthera.2020.107697. Epub 2020 Oct 6.

DOI:10.1016/j.pharmthera.2020.107697
PMID:33035577
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC7537645/
Abstract

Malaria has been a global epidemic health threat since ancient times. It still claims roughly half a million lives every year in this century. Artemisinin and its derivatives, are frontline antimalarial drugs known for their efficacy and low toxicity. After decades of wide use, artemisinins remain our bulwark against malaria. Here, we review decades of efforts that aim to understand the mechanism of action (MOA) of artemisinins, which help explain the specificity and potency of this anti-malarial drug. We summarize the methods and approaches employed to unravel the MOA of artemisinin over the last three decades, showing how the development of advanced techniques can help provide mechanistic insights and resolve some long-standing questions in the field of artemisinin research. We also provide examples to illustrate how to better repurpose artemisinins for anti-cancer therapies by leveraging on MOA. These examples point out a practical direction to engineer artemisinin for broader applications beyond malaria.

摘要

疟疾自古以来一直是全球流行的健康威胁。在本世纪,它每年仍夺走大约 50 万人的生命。青蒿素及其衍生物是疗效好、毒性低的一线抗疟药物。经过几十年的广泛使用,青蒿素仍然是我们对抗疟疾的堡垒。在这里,我们回顾了几十年来旨在了解青蒿素作用机制(MOA)的努力,这有助于解释这种抗疟药物的特异性和效力。我们总结了过去三十年中用于揭示青蒿素 MOA 的方法和途径,展示了先进技术的发展如何有助于提供机制见解并解决青蒿素研究领域的一些长期存在的问题。我们还提供了一些例子来说明如何通过利用 MOA 将青蒿素更好地用于癌症治疗。这些例子指出了一种实用的方向,即用工程方法来设计青蒿素,使其在疟疾以外的更广泛的应用中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea2/7537645/77b106e81e2b/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea2/7537645/13a961839ebb/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea2/7537645/f64234293ca5/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea2/7537645/77b106e81e2b/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea2/7537645/13a961839ebb/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea2/7537645/f64234293ca5/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea2/7537645/77b106e81e2b/gr3_lrg.jpg

相似文献

1
Advances in the research on the targets of anti-malaria actions of artemisinin.青蒿素抗疟作用靶点研究进展。
Pharmacol Ther. 2020 Dec;216:107697. doi: 10.1016/j.pharmthera.2020.107697. Epub 2020 Oct 6.
2
Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.青蒿素类抗疟药作用机制的思考:第1部分——“碳自由基”和“血红素”假说
Infect Disord Drug Targets. 2013 Aug;13(4):217-77. doi: 10.2174/1871526513666131129155708.
3
The birth of artemisinin.青蒿素的诞生。
Pharmacol Ther. 2020 Dec;216:107658. doi: 10.1016/j.pharmthera.2020.107658. Epub 2020 Aug 8.
4
[Combined antimalarial therapy using artemisinin].[使用青蒿素的联合抗疟疗法]
Parassitologia. 2004 Jun;46(1-2):85-7.
5
The threat of artemisinin resistant malaria in Southeast Asia.东南亚青蒿素耐药性疟疾的威胁。
Travel Med Infect Dis. 2016 Nov-Dec;14(6):548-550. doi: 10.1016/j.tmaid.2016.11.016. Epub 2016 Nov 30.
6
Can artemisinin and its derivatives treat malaria in a host-directed manner?青蒿素及其衍生物能否以宿主为导向的方式治疗疟疾?
Biochem Pharmacol. 2024 Jul;225:116260. doi: 10.1016/j.bcp.2024.116260. Epub 2024 May 3.
7
Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets.疟原虫对青蒿素类药物的敏感性:神奇子弹击中难以捉摸的目标。
Trends Parasitol. 2011 Feb;27(2):73-81. doi: 10.1016/j.pt.2010.11.006. Epub 2010 Dec 18.
8
Artemisinin resistance, some facts and opinions.青蒿素耐药性:一些事实与观点
J Infect Dev Ctries. 2015 Jul 4;9(6):597-9. doi: 10.3855/jidc.7015.
9
Current scenario of artemisinin and its analogues for antimalarial activity.青蒿素及其类似物的抗疟活性的现状。
Eur J Med Chem. 2019 Feb 1;163:804-829. doi: 10.1016/j.ejmech.2018.12.007. Epub 2018 Dec 13.
10
Haemolysis associated with the treatment of malaria with artemisinin derivatives: a systematic review of current evidence.青蒿素衍生物治疗疟疾相关的溶血反应:当前证据的系统评价
Int J Infect Dis. 2014 Dec;29:268-73. doi: 10.1016/j.ijid.2014.09.007. Epub 2014 Nov 1.

引用本文的文献

1
Glucose-functionalized redox-responsive dihydroartemisinin prodrug nanosystem for targeted malaria therapy.用于靶向疟疾治疗的葡萄糖功能化氧化还原响应性双氢青蒿素前药纳米系统。
Int J Pharm X. 2025 Jul 31;10:100370. doi: 10.1016/j.ijpx.2025.100370. eCollection 2025 Dec.
2
Interaction Between Human Gut Microbiota and Artemisinin: A Multi-Omics Perspective.从多组学角度看人类肠道微生物群与青蒿素之间的相互作用
ACS Omega. 2025 May 15;10(21):21929-21938. doi: 10.1021/acsomega.5c01983. eCollection 2025 Jun 3.
3
Polymorphisms in Pfkelch13 domains before and after the introduction of artemisinin-based combination therapy in Southwest Nigeria.

本文引用的文献

1
Anti-SARS-CoV-2 Potential of Artemisinins In Vitro.青蒿素体外抗新型冠状病毒 2 的潜力
ACS Infect Dis. 2020 Sep 11;6(9):2524-2531. doi: 10.1021/acsinfecdis.0c00522. Epub 2020 Aug 18.
2
Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19.抗疟药物青蒿素及其衍生物与 SARS-CoV-2 刺突蛋白的 Lys353 和 Lys31 结合热点的结合能力强于羟氯喹:青蒿琥酯可能被重新用于治疗 COVID-19。
J Biomol Struct Dyn. 2021 Oct;39(16):6184-6194. doi: 10.1080/07391102.2020.1796809. Epub 2020 Jul 22.
3
在尼日利亚西南部引入以青蒿素为基础的联合疗法前后,Pfkelch13结构域中的多态性
PLoS One. 2025 Mar 31;20(3):e0316479. doi: 10.1371/journal.pone.0316479. eCollection 2025.
4
Advanced RPL19-TRAP-seq method reveals mechanism of action of bioactive compounds.先进的RPL19-TRAP-seq方法揭示了生物活性化合物的作用机制。
Nat Prod Bioprospect. 2025 Mar 5;15(1):16. doi: 10.1007/s13659-025-00500-3.
5
Ultrastructural Changes in the Tegument and Tissues of Fasciola hepatica Adults and Their Eggs Due to the Effect of an Ethyl Acetate Extract of Artemisia ludoviciana Nutt. spp Mexicana.由于墨西哥艾菊乙酸乙酯提取物的作用,肝片吸虫成虫及其虫卵的皮层和组织的超微结构变化
Acta Parasitol. 2024 Dec;69(4):2016-2030. doi: 10.1007/s11686-024-00933-9. Epub 2024 Oct 25.
6
Bifunctional Sesquiterpene/Diterpene Synthase Agr2 from Gives Rise to the Novel Diterpene Cyclocybene.双功能倍半萜/二萜合酶 Agr2 来自 产生新型二萜环巴烯。
ACS Chem Biol. 2024 Oct 18;19(10):2144-2151. doi: 10.1021/acschembio.4c00178. Epub 2024 Sep 18.
7
Analysis of US Marketed Artemisinin Supplements for Use in Dogs.美国市场上用于犬类的青蒿素补充剂分析。
J Vet Pharmacol Ther. 2025 Jan;48(1):56-60. doi: 10.1111/jvp.13480. Epub 2024 Aug 24.
8
Enhancement of Anticancer Potential of Artemisinin Derivatives through N-glycosylation.通过 N-糖基化增强青蒿素衍生物的抗癌潜力。
Curr Top Med Chem. 2024;24(23):2074-2091. doi: 10.2174/0115680266322676240724114536.
9
Photoaffinity probe-based antimalarial target identification of artemisinin in the intraerythrocytic developmental cycle of .基于光亲和探针的青蒿素在疟原虫红细胞内发育周期中的抗疟靶点鉴定 。 你提供的原文似乎不完整,句末的“of.”后面缺少具体内容。
Imeta. 2024 Feb 19;3(2):e176. doi: 10.1002/imt2.176. eCollection 2024 Apr.
10
Differential Anti-Fibrotic and Remodeling Responses of Human Dermal Fibroblasts to sp., Artemisinin, and Its Derivatives.人真皮成纤维细胞对 sp.、青蒿素及其衍生物的抗纤维化和重塑反应的差异。
Molecules. 2024 May 2;29(9):2107. doi: 10.3390/molecules29092107.
A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites.
Kelch13 定义的内吞途径介导疟原虫对青蒿素的耐药性。
Science. 2020 Jan 3;367(6473):51-59. doi: 10.1126/science.aax4735.
4
Decreased K13 Abundance Reduces Hemoglobin Catabolism and Proteotoxic Stress, Underpinning Artemisinin Resistance.疟原虫 K13 丰度降低可减少血红蛋白代谢和蛋白毒性应激,为青蒿素耐药提供了基础。
Cell Rep. 2019 Nov 26;29(9):2917-2928.e5. doi: 10.1016/j.celrep.2019.10.095.
5
Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents.共价型疟原虫选择性蛋白酶体抑制剂在体外产生耐药性的倾向较低,并与多种抗疟药物具有协同作用。
PLoS Pathog. 2019 Jun 6;15(6):e1007722. doi: 10.1371/journal.ppat.1007722. eCollection 2019 Jun.
6
A Temporizing Solution to "Artemisinin Resistance".针对“青蒿素耐药性”的一种临时解决方案。
N Engl J Med. 2019 May 30;380(22):2087-2089. doi: 10.1056/NEJMp1901233. Epub 2019 Apr 24.
7
Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome.青蒿素通过破坏蛋白质和抑制蛋白酶体来杀死疟原虫。
Nat Commun. 2018 Sep 18;9(1):3801. doi: 10.1038/s41467-018-06221-1.
8
Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistance.抗疟蛋白酶体抑制剂揭示了亚基间相互作用的副作用敏感性和耐药性的适应代价。
Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):E6863-E6870. doi: 10.1073/pnas.1806109115. Epub 2018 Jul 2.
9
Artemisinin and its derivatives in treating helminthic infections beyond schistosomiasis.青蒿素及其衍生物在治疗血吸虫病以外的寄生虫感染中的应用。
Pharmacol Res. 2018 Jul;133:77-100. doi: 10.1016/j.phrs.2018.04.025. Epub 2018 May 1.
10
Beyond malaria: The inhibition of viruses by artemisinin-type compounds.超越疟疾:青蒿素类化合物对病毒的抑制作用。
Biotechnol Adv. 2018 Nov 1;36(6):1730-1737. doi: 10.1016/j.biotechadv.2018.01.001. Epub 2018 Jan 3.